Ignite Creation Date:
2024-05-05 @ 10:32 PM
Last Modification Date:
2024-10-26 @ 10:19 AM
Study NCT ID:
NCT01121588
Status:
TERMINATED
Last Update Posted:
2023-11-09
First Post:
2010-05-10
Brief Title:
An Investigational Drug Crizotinib PF-02341066 Is Being Studied In Tumors Except Non-Small Cell Lung Cancer That Are Positive For Anaplastic Lymphoma Kinase ALK
Sponsor:
Pfizer
Organization:
Pfizer
Organization Data
Organization:
Pfizer
Class:
INDUSTRY
Study ID:
A8081013
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Pfizer
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None